{"id":731,"date":"2017-05-30T08:03:50","date_gmt":"2017-05-30T08:03:50","guid":{"rendered":"https:\/\/californiaheartclinic.com\/?p=731"},"modified":"2021-02-07T12:53:51","modified_gmt":"2021-02-07T12:53:51","slug":"fda-clears-ra-medicals-dabra-atherectomy-system-to-treat-pad","status":"publish","type":"post","link":"https:\/\/californiaheartclinic.com\/mx\/fda-clears-ra-medicals-dabra-atherectomy-system-to-treat-pad\/","title":{"rendered":"La FDA aprueba el sistema de aterectom\u00eda Dabra de Ra Medical para tratar la enfermedad arterial perif\u00e9rica (PAD)"},"content":{"rendered":"<p>Ra Medical Systems, Inc. anunci\u00f3 que la Administraci\u00f3n de Alimentos y Medicamentos de EE. UU. Ha otorgado la autorizaci\u00f3n de mercado para el sistema de aterectom\u00eda Dabra (Destrucci\u00f3n de bloqueos arterioscler\u00f3ticos por ablaci\u00f3n por radiaci\u00f3n l\u00e1ser) de la compa\u00f1\u00eda con cat\u00e9ter para el tratamiento de la enfermedad arterial perif\u00e9rica. En octubre de 2016, la empresa&nbsp;<a href=\"http:\/\/evtoday.com\/2016\/09\/ra-medical-systems-dabra-atherectomy-system-approved-in-europe\" target=\"_blank\" rel=\"noreferrer noopener\">Anunciado<\/a>&nbsp;que el sistema Dabra fue aprobado en Europa.<\/p>\n\n\n\n<p>El Dr. Ehtisham Mahmud, presidente del estudio fundamental del dispositivo, explic\u00f3 en el anuncio de la compa\u00f1\u00eda #8217: \u201cEl estudio fundamental de Dabra demostr\u00f3 el \u00e9xito del 95% sin ning\u00fan evento adverso cl\u00ednicamente significativo. Adem\u00e1s, el cat\u00e9ter Dabra es \u00fanico en su capacidad para atravesar oclusiones totales cr\u00f3nicas sin tener que atravesar la lesi\u00f3n con un alambre, y tambi\u00e9n reduce y modifica los bloqueos arteriales, lo que lo convierte en una herramienta cl\u00ednica invaluable \u201d. El Dr. Mahmud es Jefe de Medicina Cardiovascular , Director del Centro de Medicina Cardiovascular Sulpizio, y Director de Cardiolog\u00eda Intervencionista en la Escuela de Medicina UC San Diego en San Diego, California.<\/p>\n\n\n\n<p>El 1 de junio, la compa\u00f1\u00eda anunci\u00f3 el lanzamiento comercial de Dabra en los Estados Unidos. El Dr. Athar Ansari, de la Cl\u00ednica Vascular y Card\u00edaca de California en El Centro, California, realiz\u00f3 el primer procedimiento posterior a la limpieza utilizando el sistema Dabra a trav\u00e9s del acceso a la arteria braquial para tratar a un paciente con bloqueos arteriales.<\/p>\n\n\n\n<p>Adem\u00e1s, la compa\u00f1\u00eda inform\u00f3 que Raghotham Patlola, MD, presentar\u00e1 nuevos datos sobre Dabra el 2 de junio en la Conferencia de Nuevos Horizontes Cardiovasculares en Nueva Orleans, Louisiana. En la presentaci\u00f3n, &quot;Nuevo l\u00e1ser inal\u00e1mbrico para el tratamiento de oclusiones totales cr\u00f3nicas&quot;, el Dr. Patlola destacar\u00e1 la seguridad y eficacia de Dabra &amp; #8217, incluida una tasa de \u00e9xito 95% sin eventos adversos en el estudio cl\u00ednico. El Dr. Patlola est\u00e1 en el Louisiana Cardiovascular &amp; Limb Salvage Center en Lafayette, Louisiana.<\/p>\n\n\n\n<p>Fuente: <a href=\"https:\/\/evtoday.com\/news\/fda-clears-ra-medicals-dabra-atherectomy-system-to-treat-pad\">https:\/\/evtoday.com\/news\/fda-clears-ra-medicals-dabra-atherectomy-system-to-treat-pad<\/a><br><\/p>","protected":false},"excerpt":{"rendered":"<p>Ra Medical Systems, Inc. announced that the US Food and Drug Administration has granted market clearance for the company\u2019s Dabra (Destruction of Arteriosclerotic Blockages by laser Radiation Ablation) atherectomy system with catheter for the treatment of peripheral artery disease. In October 2016, the company&nbsp;announced&nbsp;that the Dabra system was approved in Europe. Ehtisham Mahmud, MD, Chair [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":744,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"FDA Approves Ra Medical Laser to Treat Peripheral Artery Disease (PAD)","_seopress_titles_desc":"California Heart &amp; Vascular Clinic is using FDA approved Ra Medical lasers for the non-invasive treatment of lower extremity peripheral artery disease (PAD). ","_seopress_robots_index":"","inline_featured_image":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-731","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","entry","has-media"],"jetpack_featured_media_url":"https:\/\/californiaheartclinic.com\/wp-content\/uploads\/2019\/12\/fda.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/posts\/731","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/comments?post=731"}],"version-history":[{"count":0,"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/posts\/731\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/media\/744"}],"wp:attachment":[{"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/media?parent=731"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/categories?post=731"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/californiaheartclinic.com\/mx\/wp-json\/wp\/v2\/tags?post=731"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}